歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01672 歌礼制药-B

休市中 11-22 16:08:13

1.770

-0.070

-3.80%

最高1.840	最低1.710	成交量162.40万
今开1.790	昨收1.840	日振幅7.07%
总市值17.42亿	流通市值17.42亿	总股本9.84亿
成交额287.13万	换手率0.17%	流通股本9.84亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01672","market":"HK","secType":"STK","nameCN":"歌礼制药-B","latestPrice":1.77,"timestamp":1732262893015,"preClose":1.84,"halted":0,"volume":1624000,"delay":0,"floatShares":984000000,"shares":984000000,"eps":-0.14446752,"marketStatus":"休市中","marketStatusCode":7,"change":-0.07,"latestTime":"11-22 16:08:13","open":1.79,"high":1.84,"low":1.71,"amount":2871300,"amplitude":0.070652,"askPrice":1.78,"askSize":23000,"bidPrice":1.77,"bidSize":25000,"shortable":0,"etf":0,"ttmEps":-0.26679043331906116,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"listingDate":1533052800000,"adjPreClose":1.84,"openAndCloseTimeList":[[1732239000000,1732248000000],[1732251600000,1732262400000]],"volumeRatio":0.830011,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01672","defaultTab":"news","newsList":[{"id":"2485237148","title":"歌礼制药-B(01672)11月22日斥资101.54万港元回购57.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485237148","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485237148?lang=zh_cn&edition=full","pubTime":"2024-11-22 18:13","pubTimestamp":1732270402,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，于2024年11月22日该公司斥资101.54万港元回购57.5万股，回购价格为每股1.72-1.77港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01672","BK1191","01477","BK1515","BK1574"],"gpt_icon":0},{"id":"1143489032","title":"异动解读 | 01672 歌礼制药-B盘中大跌5.43% 回购举措释疲软迹象","url":"https://stock-news.laohu8.com/highlight/detail?id=1143489032","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143489032?lang=zh_cn&edition=full","pubTime":"2024-11-22 11:42","pubTimestamp":1732246971,"startTime":"0","endTime":"0","summary":"01672 歌礼制药-B盘中股价大跌5.43%,引发市场广泛关注。根据公司公布的回购公告,歌礼制药-B于2024年11月21日回购了自身7.6万股,最低回购价格为1.67港元,回购规模较小,折射出公司当前现金流不够充裕。同时,公司未公布具体回购原因和计划,进一步引发外界对其前景的担忧。综合来看,歌礼制药-B本轮盘中大跌与其规模较小的股份回购行为不无关系,回购计划未能达到提振股价的预期效果,反而助长了市场对公司基本面的忧虑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 01672 歌礼制药-B盘中大跌5.43% 回购举措释疲软迹象","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01672"],"gpt_icon":0},{"id":"2485577814","title":"歌礼制药-B(01672)11月21日斥资12.8万港元回购7.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485577814","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485577814?lang=zh_cn&edition=full","pubTime":"2024-11-21 17:47","pubTimestamp":1732182426,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，于2024年11月21日该公司斥资12.8万港元回购7.6万股，回购价格为每股1.67-1.70港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214097.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","01477","BK1574","BK1161","BK1191","BK1515"],"gpt_icon":0},{"id":"2485552844","title":"歌礼制药-B11月21日获主力加仓173万元 环比增加620.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485552844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485552844?lang=zh_cn&edition=full","pubTime":"2024-11-21 16:15","pubTimestamp":1732176929,"startTime":"0","endTime":"0","summary":"11月21日, 歌礼制药-B股价涨9.52%，报收1.84元，成交金额667万元，换手率0.39%，振幅10.71%，量比2.66。歌礼制药-B今日主力资金净流入173万元，上一交易日主力净流入24万元，今日环比增加620.83%。该股近5个交易日上涨21.85%，主力资金累计净流入222万元；近20日主力资金累计净流入339万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121161549abd427b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121161549abd427b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","BK1515","01672","BK1191","BK1161","BK1574"],"gpt_icon":0},{"id":"1117526150","title":"异动解读 | 歌礼制药-B盘中大涨5.36% 主要产品管线获看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1117526150","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117526150?lang=zh_cn&edition=full","pubTime":"2024-11-21 13:46","pubTimestamp":1732167991,"startTime":"0","endTime":"0","summary":"歌礼制药-B(01672)周四盘中大涨5.36%,引发市场关注。\n\n分析人士认为,此次股价上涨或与公司主要产品管线获看好有关。根据公开资料,歌礼制药主攻病毒性疾病、非酒精性脂肪性肝炎和肿瘤等领域的药物研发,其主要产品管线包括利托那韦、盐酸拉维达韦、达诺瑞韦钠等治疗病毒性疾病的药物,以及ASC40、ASC41、ASC42等治疗非酒精性脂肪性肝炎的药物,还有ASC60、ASC61等肿瘤药物。投资者对公司在上述细分领域的产品前景抱有信心,或是推动股价上涨的主因。\n\n不过,公司最新财报显示净利润出现亏损,仍需进一步关注其盈利状况。市场人士也指出,该股资金流入明显,成交额较高,有助于支撑股价表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 歌礼制药-B盘中大涨5.36% 主要产品管线获看好","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01672"],"gpt_icon":0},{"id":"2485433417","title":"歌礼制药-B盘中异动 股价大涨5.36%报1.770港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485433417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485433417?lang=zh_cn&edition=full","pubTime":"2024-11-21 13:24","pubTimestamp":1732166649,"startTime":"0","endTime":"0","summary":"2024年11月21日下午盘13时24分，歌礼制药-B股票出现异动，股价急速拉升5.36%。截至发稿，该股报1.770港元/股，成交量201.9万股，换手率0.21%，振幅6.55%。资金方面，该股资金流入233.63万港元，流出101.367万港元。歌礼制药-B股票所在的生物技术行业中，整体涨幅为0.18%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121132409abd3cd32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121132409abd3cd32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","01672","BK1161","01477","BK1574","BK1191"],"gpt_icon":0},{"id":"2485433145","title":"歌礼制药-B(01672)上涨5.36%，报1.77元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485433145","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485433145?lang=zh_cn&edition=full","pubTime":"2024-11-21 13:24","pubTimestamp":1732166647,"startTime":"0","endTime":"0","summary":"11月21日，歌礼制药-B(01672)盘中上涨5.36%，截至13:24，报1.77元/股，成交345.27万元。歌礼制药有限公司是一家创新研发驱动型生物科技公司，主要从事病毒性疾病、非酒精性脂肪性肝炎和肿瘤等三大医疗领域的新药研发、生产和商业化。该公司在浙江绍兴滨海新城拥有约17,000平方米的生产基地，设计年产能为1.3亿片，拥有多款在研药物并已取得药品生产许可证。截至2023年年报，歌礼制药-B营业总收入5659.6万元、净利润-1.45亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/21132445515377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","01477","BK1191","BK1574","01672","BK1515"],"gpt_icon":0},{"id":"2485435381","title":"歌礼制药－Ｂ(01672)股价上升5.357%，现价港币$1.77","url":"https://stock-news.laohu8.com/highlight/detail?id=2485435381","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485435381?lang=zh_cn&edition=full","pubTime":"2024-11-21 13:24","pubTimestamp":1732166640,"startTime":"0","endTime":"0","summary":"[上升股]歌礼制药－Ｂ(01672) 股价在下午01:24比前收市价上升5.357%，现股价为港币$1.77。至目前为止，今日最高价为$1.77，而最低价为$1.66。总成交量为193.2万股，总成交金额为港币$329.971万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR241121593/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","BK1574","BK1161","BK1515","01477","01672"],"gpt_icon":0},{"id":"2484600801","title":"歌礼制药-B(01672)11月20日斥资49.93万港元回购30万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2484600801","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484600801?lang=zh_cn&edition=full","pubTime":"2024-11-20 18:09","pubTimestamp":1732097390,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，于2024年11月20日，该公司斥资49.93万港元回购30万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1213530.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01477","BK1574","BK1515","01672","BK1191"],"gpt_icon":0},{"id":"2484634918","title":"歌礼制药-B(01672)11月19日斥资50.2万港元回购30万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2484634918","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484634918?lang=zh_cn&edition=full","pubTime":"2024-11-19 17:42","pubTimestamp":1732009329,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，于2024年11月19日斥资50.2万港元回购30万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212915.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","BK1161","BK1515","BK1191","01477","BK1574"],"gpt_icon":0},{"id":"2484864470","title":"歌礼制药-B(01672)11月18日斥资83.11万港元回购50万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2484864470","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484864470?lang=zh_cn&edition=full","pubTime":"2024-11-18 18:18","pubTimestamp":1731925114,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，于2024年11月18日该公司斥资83.11万港元回购50万股，回购价格为每股1.60-1.68港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212369.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","01672","BK1161","BK1515","01477","BK1191"],"gpt_icon":0},{"id":"2484107026","title":"歌礼制药-B11月18日获主力加仓23万元 环比增加2200.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484107026","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484107026?lang=zh_cn&edition=full","pubTime":"2024-11-18 16:15","pubTimestamp":1731917746,"startTime":"0","endTime":"0","summary":"11月18日, 歌礼制药-B股价涨3.70%，报收1.68元，成交金额275万元，换手率0.17%，振幅8.64%，量比0.73。歌礼制药-B今日主力资金净流入23万元，上一交易日主力净流入1万元，今日环比增加2200.00%。该股近5个交易日下跌0.59%，主力资金累计净流出70万元；近20日主力资金累计净流入141万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118161622abcbd9f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118161622abcbd9f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01477","01672","BK1191","BK1515","BK1574"],"gpt_icon":0},{"id":"2483332867","title":"歌礼制药-B(01672)11月15日斥资96.2万港元回购60万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483332867","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483332867?lang=zh_cn&edition=full","pubTime":"2024-11-15 18:27","pubTimestamp":1731666467,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，于2024年11月15日该公司斥资96.2万港元回购60万股，回购价格为每股1.49-1.66港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211688.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1574","BK1191","01672","01477","BK1161"],"gpt_icon":0},{"id":"2483627397","title":"歌礼制药-B(01672)上涨6.62%，报1.61元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483627397","media":"金融界","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483627397?lang=zh_cn&edition=full","pubTime":"2024-11-15 13:00","pubTimestamp":1731646809,"startTime":"0","endTime":"0","summary":"11月15日，歌礼制药-B(01672)盘中上涨6.62%，截至13:00，报1.61元/股，成交116.1万元。歌礼制药有限公司是一家创新研发驱动型生物科技公司，主要从事病毒性疾病、非酒精性脂肪性肝炎和肿瘤等三大医疗领域的新药研发、生产和商业化。该公司在浙江绍兴滨海新城拥有约17,000平方米的生产基地，设计年产能为1.3亿片，拥有多款在研药物并已取得药品生产许可证。截至2023年年报，歌礼制药-B营业总收入5659.6万元、净利润-1.45亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/15130045328754.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","01672","BK1161","BK1515","01477","BK1191"],"gpt_icon":0},{"id":"2483692394","title":"歌礼制药－Ｂ(01672)股价上升5.298%，现价港币$1.59","url":"https://stock-news.laohu8.com/highlight/detail?id=2483692394","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483692394?lang=zh_cn&edition=full","pubTime":"2024-11-15 11:56","pubTimestamp":1731642960,"startTime":"0","endTime":"0","summary":"[上升股]歌礼制药－Ｂ(01672) 股价在上午11:56比前收市价上升5.298%，现股价为港币$1.59。至目前为止，今日最高价为$1.59，而最低价为$1.48。总成交量为52.9万股，总成交金额为港币$80.671万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2411151200/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01672","BK1161","BK1191","BK1515","BK1574","01477"],"gpt_icon":0},{"id":"2483888824","title":"歌礼制药-B(01672)11月14日斥资92.74万港元回购60万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483888824","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483888824?lang=zh_cn&edition=full","pubTime":"2024-11-14 18:24","pubTimestamp":1731579881,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，该公司于2024年11月14日斥资92.74万港元回购60万股股份，每股回购价格为1.5-1.6港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211019.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","BK1515","BK1191","01477","BK1161","BK1574"],"gpt_icon":0},{"id":"2483384602","title":"歌礼制药-B盘中异动 临近收盘股价大跌5.06%报1.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483384602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483384602?lang=zh_cn&edition=full","pubTime":"2024-11-14 15:34","pubTimestamp":1731569698,"startTime":"0","endTime":"0","summary":"2024年11月14日临近收盘15时34分，歌礼制药-B股票出现异动，股价快速下跌5.06%。截至发稿，该股报1.500港元/股，成交量105.1万股，换手率0.11%，振幅6.96%。歌礼制药-B股票所在的生物技术行业中，整体跌幅为1.70%。其相关个股中，晶泰科技、康宁杰瑞制药-B、迈博药业-B涨幅较大，振幅较大的相关个股有晶泰科技、科济药业-B、中国抗体-B，振幅分别为44.86%、17.01%、16.82%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111415345898e42956&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111415345898e42956&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","BK1515","BK1574","01672","BK1191","BK1161"],"gpt_icon":0},{"id":"2483501031","title":"歌礼制药(01672.HK)完成ASC40口服片III期临床试验患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2483501031","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483501031?lang=zh_cn&edition=full","pubTime":"2024-11-13 01:32","pubTimestamp":1731432720,"startTime":"0","endTime":"0","summary":"歌礼制药－Ｂ(01672.HK) 公布，已完成ASC40（地尼法司他）每日一次口服片治疗中、重度痤疮III期临床试验的480例患者入组。顶线结果预计将于2025年第二季度公布。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180823143226473_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180823143226473_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1396083/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01477","BK1141","03347","BK1574","BK1576","01672","BK1583","BK1161","BK1515","BK1191"],"gpt_icon":0},{"id":"2482772909","title":"歌礼制药-B(01672)完成ASC40(地尼法司他)每日一次口服片治疗痤疮III期临床试验患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2482772909","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482772909?lang=zh_cn&edition=full","pubTime":"2024-11-12 19:17","pubTimestamp":1731410249,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 公布，已完成ASC40每日一次口服片治疗中、重度痤疮III期临床试验的480例患者入组。首例患者已于2024年1月 24日入组。这项III期临床试验是一项在中国开展的随机、双盲、安慰剂对照、多中心的临床试验，旨在评估ASC40每日一次口服片治疗中、重度寻常性痤疮的安全性和疗效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209983.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","03347","BK1141","III","01672","BK1576","BK1161","01477","BK1574","BK4134","BK1191","BK1583"],"gpt_icon":0},{"id":"2482712287","title":"歌礼制药-B(01672)11月12日斥资30.1万港元回购18.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482712287","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482712287?lang=zh_cn&edition=full","pubTime":"2024-11-12 18:51","pubTimestamp":1731408702,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，于2024年11月12日该公司斥资30.1万港元回购18.7万股，回购价格为每股1.60-1.61港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209959.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","BK1574","01477","BK1515","BK1161","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascletis.com","stockEarnings":[{"period":"1week","weight":0.0926},{"period":"1month","weight":0.3015},{"period":"3month","weight":1.2692},{"period":"6month","weight":0.4048},{"period":"1year","weight":-0.0585},{"period":"ytd","weight":0.2123}],"compareEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":-0.0737},{"period":"3month","weight":0.0919},{"period":"6month","weight":0.0334},{"period":"1year","weight":0.0736},{"period":"ytd","weight":0.128}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"歌礼制药有限公司是一家主要从事医药产品的研发、生产、营销及销售的中国投资控股公司。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。病毒性疾病产品管线包括利托那韦、盐酸拉维达韦、达诺瑞韦钠等。非酒精性脂肪性肝炎产品管线包括ASC40、ASC41、ASC42等。肿瘤产品管线包括ASC60、ASC61等。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.102992},{"month":2,"riseRate":0.666667,"avgChangeRate":0.004802},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.105976},{"month":4,"riseRate":0.5,"avgChangeRate":-0.033468},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.025765},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.058787},{"month":7,"riseRate":0.5,"avgChangeRate":0.006985},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.090298},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.044648},{"month":10,"riseRate":0.571429,"avgChangeRate":-0.021896},{"month":11,"riseRate":0.857143,"avgChangeRate":0.159862},{"month":12,"riseRate":0.5,"avgChangeRate":-0.003643}],"exchange":"SEHK","name":"歌礼制药-B","nameEN":"ASCLETIS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"歌礼制药-B,01672,歌礼制药-B股票,歌礼制药-B股票老虎,歌礼制药-B股票老虎国际,歌礼制药-B行情,歌礼制药-B股票行情,歌礼制药-B股价,歌礼制药-B股市,歌礼制药-B股票价格,歌礼制药-B股票交易,歌礼制药-B股票购买,歌礼制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}